Mumbai, August 13, 2007
Lupin Ltd. (Lupin), announced on Monday that it has appointed Ramesh Swaminathan as President – Finance & Planning. He will be based at Lupin's Corporate Office in Mumbai. A Chartered Accountant with over two decades experience, Mr. Swaminathan leads the Finance and Planning function and will facilitate the organization in strengthening its processes resulting in sustainable growth, improved cost management and world class practices in Financial Management.
Prior to joining Lupin Mr. Swaminathan was with Henkel, Germany where he held corporate responsibilities as Regional Financial Controller for several countries across Central and Eastern Europe and the Middle East. Prior to that assignment, he was the CFO of Henkel India. He has also worked with companies such as VST Industries, the SPIC group and Standard Chartered Bank.
Mr. Swaminathan is a member of the Institute of Chartered Management Accountants, UK and the Institute of Company Secretaries in India.
"Given our global presence and growth plans, it is important that we invest on people development and attract top talent from global leaders. We have attracted some of the best international talent in the area of Research & Development, Finance, etc. Ramesh Swaminathan's international experience will help us bring globally benchmarked best practices to Lupin," Dr. Kamal Sharma, Managing Director, Lupin Limited said.
About Lupin
Headquartered in Mumbai, Lupin Ltd. is a leading pharmaceutical company with strong research focus. It has a programme for developing New Chemical Entities. The company has state-of-the-art R&D center in Pune. The company is a leading global player in Anti-TB, Cephalosporins (anti-infectives) and cardiovascular drugs (prils and statins) and has a notable presence in the areas of diabetology, NSAIDS and Asthma.
For the quarter ended June 2007, Lupin's revenues and profit after tax were Rs. 617.3 crore (US$ 152 million) and Rs. 78.4 crore (US$ 19 million) respectively.
|
